The concept of endophenotypes in psychiatric diseases meeting the expectations?

Pharmacopsychiatry

Volumn 41, Issue SUPPL. 1, 2008, Pages

  Puls, Imke ^a   Gallinat, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTION; BRAIN ELECTROPHYSIOLOGY; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; FAMILY STUDY; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC EPISTASIS; GENETICS; HUMAN; MENTAL DISEASE; NEUROIMAGING; PHENOTYPE; PRIORITY JOURNAL; RELIABILITY; REVIEW; TWINS;

FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENTAL DISORDERS; PHENOTYPE;

EID: 54749097436     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081462     Document Type: Review

References (79)

1. Almasy L, Blangero J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am J Med Genet 2001; 105: 42-44
2. Bearden CE, Freimer NB. Endophenotypes for psychiatric disorders: ready for primetime? Trends Genet 2006; 22: 306-313
3. Bender S, Weisbrod M, Resch F. Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia? J Neural Transm 2007; 114: 1199-1215
4. Bender W, Albus M, Moller HJ, Tretter F. Towards systemic theories in biological psychiatry. Pharmacopsychiatry 2006; 39 (Suppl 1): S4-S9
5. Bosl WJ. Systems biology by the rules: hybrid intelligent systems for pathway modeling and discovery. BMC Syst Biol 2007; 1: 13
6. Braff DL, Light GA. The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Dialogues Clin Neurosci 2005; 7: 125-135
7. Cannon TD. The inheritance of intermediate phenotypes for schizophrenia. Curr Opin Psychiatry 2005; 18: 135-140
8. Cannon TD, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol 2006; 2: 267-290
9. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 2004; 429: 446-452
10. Castellanos FX, Tannock R. Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002; 3: 617-628
11. Cook Jr EH. Genetics of autism. Child Adolesc Psycbiatr Clin N Am 2001; 10: 333-350
12. Craddock N, Owen MJ, O'Donovan MC. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol Psychiatry 2006; 11: 446-458
13. Cryan JF, Slattery DA. Animal models of mood disorders: Recent developments. Curr Opin Psychiatry 2007; 20: 1-7
14. Dworkin RH, Lenzenweger MF. Symptoms and the genetics of schizophrenia: implications for diagnosis. Am J Psychiatry 1984; 141: 1541-1546
15. Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and bippocampal function. Cell 2003; 112: 257-269
16. Flint J, Munafo MR. The endophenotype concept in psychiatric genetics. Psychol Med 2007; 37: 163-180
17. Gallinat J, Bajbouj M, Sander T et al. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 2003; 54: 40-48
18. Gallinat J, Gotz T, Kalus P et al. Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J Cogn Neurosci 2007; 19: 59-68
19. Gallinat J, Obermayer K, Heinz A. Systems Neurobiology of the Dysfunctional Brain: Schizophrenia. Pharmacopsychiatry 2007; 40: 40-44
20. Gallinat J, Senkowski D, Wernicke C et al. Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology 2003; 28: 530-532
21. Gallinat J, Strohle A, Lang UE et al. Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety. Neuroimage 2005; 26: 123-131
22. Gershon ES, Goldin LR. Clinical methods in psychiatric genetics. I. Robustness of genetic marker investigative strategies. Acta Psychiatr Scand 1986; 74: 113-118
23. Glahn DC, Paus T, Thompson PM. Imaging genomics: mapping the influence of genetics on brain structure and function. Hum Brain Mapp 2007; 28: 461-463
24. Glahn DC, Thompson PM, Blangero J. Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Hum Brain Mapp 2007; 28: 488-501
25. Goldman D, Ducci F. Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. Scientific World Journal 2007; 7: 124-130
26. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-645
27. Gottesman II, Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry 1973; 122: 15-30
28. Gould TD, Gottesman II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 2006; 5: 113-119
29. Graepel T, Obermayer K. A stochastic self-organizing map for proximity data. Neural Comput 1999; 11: 139-155
30. Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006; 67: e12
31. Greenberg DA, Delgado-Escueta AV, Widelitz H et al. Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet 1988; 31: 185-192
32. Greenwood TA, Braff DL, Light GA et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 2007; 64: 1242-1250
33. Gur RE, Turetsky BI, Loughead J et al. Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. Am J Psychiatry 2007; 164: 442-449
34. Hall MH, Rijsdijk F, Picchioni M et al. Substantial shared genetic influences on schizophrenia and event-related potentials. Am J Psychiatry 2007; 164: 804-812
35. Hariri AR, Weinberger DR. Imaging genomics. Br Med Bull 2003; 65: 259-270
36. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 2006; 60: 93-105
37. Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology 2004; 29: 1765-1781
38. Hegerl U, Gallinat J, Mrowinski D. Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 1994; 17: 1-13
39. Heinz A, Braus DF, Smolka MN et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005; 8: 20-21
40. Hines LM, Ray L, Hutchison K, Tabakoff B. Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci 2005; 7: 153-163
41. Horne BD, Anderson JL, Carlquist JF et al. Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet 2005; 69: 176-186
42. John B, Lewis KR. Chromosome variability and geographic distribution in insects. Science 1966; 152: 711-721
43. Kathmann N, Hochrein A, Uwer R, Bondy B. Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. Am J Psychiatry 2003; 160: 696-702
44. Lalouel JM, Le Mignon L, Simon M et al. Genetic analysis of idiopathic hemochromatosis using both qualitative (disease status) and quantitative (serum iron) information. Am J Hum Genet 1985; 37: 700-718
45. Lang UE, Bajbouj M, Sander T, Gallinat J. Gender-dependent association of the functional catechol-O-methyltransferase Val158Met genotype with sensation seeking personality trait. Neuropsychopharmacology 2007, in print
46. Lango H, Weedon MN. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice? J Intern Med 2008; 263: 16-27
47. Lawrie SM, Hall J, MacIntosh AM, Cunningham-Owens DG, Johnstone EC. Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential. Br J Pharmacol 2008, in print
48. Leboyer M, Bellivier F, Nosten-Bertrand M et al. Psychiatric genetics: search for phenotypes. Trends Neurosci 1998; 21: 102-105
49. Leppert M, Burt R, Hughes JP et al. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 1990; 322: 904-908
50. Longmate JA. Complexity and power in case-control association studies. Am J Hum Genet 2001; 68: 1229-1237
51. Louchart-de la Chapelle S, Nkam I, Houy E et al. A concordance study of three electrophysiological measures in schizophrenia. Am J Psychiatry 2005; 162: 466-474
52. Makris N, Gasic GP, Seidman LJ et al. Decreased absolute amygdala volume in cocaine addicts. Neuron 2004; 44: 729-740
53. Marlow AJ, Fisher SE, Francks C et al. Use of multivariate linkage analysis for dissection of a complex cognitive trait. Am J Hum Genet 2003; 72: 561-570
54. Martin LF, Hall MH, Ross RG et al. Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. Am J Psychiatry 2007; 164: 1900-1906
55. MacDonald C, Marshall N, Sham PC et al. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 2006; 163: 478-487
56. Meyer-Lindenberg A, Nicodemus KK, Egan MF et al. False positives in imaging genetics. Neuroimage 2007
57. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006; 7: 818-827
58. Nicodemus KK, Marenco S, Batten AJ et al. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol Psychiatry 2008, in print
59. Ott J. The future of multilocus linkage analysis. Ann Med 1992; 24: 401-403
60. Pardes H, Kaufmann CA, Pincus HA, West A. Genetics and psychiatry: past discoveries, current dilemmas, and future directions. Am J Psychiatry 1989; 146: 435-443
61. Pezawas L, Meyer-Lindenberg A, Drabant EM et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828-834
62. Pezawas L, Verchinski BA, Mattay VS et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24: 10099-10102
63. Porjesz B, Rangaswamy M. Neurophysiological endophenotypes, CNS disinhibition, and risk for alcohol dependence and related disorders. Scientific World Journal 2007; 7: 131-141
64. Puls I, Mohr J, Wrase J et al. Synergistic effects of the dopaminergic and glutamatergic system on hippocampal volume in alcohol-dependent patients. Biological Psychology 2008, accepted for publication
65. Reischies FM, Neuhaus AH, Hansen ML et al. Electrophysiological and neuropsychological analysis of a delirious state: the role of the anterior cingulate gyrus. Psychiatry Res 2005; 138: 171-181
66. Rentzsch J, Jockers-Scherubi MC, Boutros NN, Gallinat J. Test-retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects. Int J Psychophysiol 2008; 67: 81-90
67. Rutter M. Psychiatric genetics: research challenges and pathways forward. Am J Med Genet 1994; 54: 185-198
68. Sanders AR, Duan J, Levinson DF et al. No significant association of 14 candidate genes with schizophrenia in a large European Ancestry Sample: Implications for psychiatric genetics. Am J Psychiatry 2008
69. Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 2004; 21: 1762-1771
70. Siever LJ. Endophenotypes in the personality disorders. Dialogues Clin Neurosci 2005; 7: 139-151
71. Sklar P, Gabriel SB, McInnis MG et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002; 7: 579-593
72. Tretter F, Scherer J. Schizophrenia, neurobiology and the methodology of systemic modeling. Pharmacopsychiatry 2006; 39 (Suppl 1): S26-S35
73. Tsuang MT, Faraone SV, Lyons MJ. Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatry Clin Neurosci 1993; 243: 131-142
74. Turner ST, Peyser PA, Kardia SL et al. Genomic loci with pleiotropic effects on coronary artery calcification. Atherosclerosis 2006; 185: 340-346
75. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992; 327: 846-852
76. Waldman ID. Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/ hyperactivity disorder. Biol Psychiatry 2005; 57: 1347-1356
77. Wijsman EM, Amos CI. Genetic analysis of simulated oligogenic traits in nuclear and extended pedigrees: summary of GAW10 contributions. Genet Epidemiol 1997; 14: 719-735
78. Winterer G, Musso F, Konrad A et al. Association of attentional network function with exon 5 variations of the CHRNA4 gene. Hum Mol Genet 2007; 16: 2165-2174
79. Zhang H, Liu L, Wang X, Gruen JR. Guideline for data analysis of genomewide association studies. Cancer Genomics Proteomics 2007; 4: 27-34